• About
  • Team
  • Portfolio
  • Case Studies
  • News
RiverVest Funds I, II & III RiverVest Fund IV Archer Seed Fund
Logo Logo Logo Logo Logo
Good-logo-for-acquisition-posting

03 Aug CASE STUDY: GOOD THERAPEUTICS

Posted at 16:26h in Case Study by kelly 0 Comments

This is a case study of RiverVest portfolio company Good Therapeutics, which was acquired by Roche in 2022 for $250 million upfront plus potential milestone returns....

Read More

24 Apr CASE STUDY: Standard Bariatrics

Posted at 19:39h in Case Study by kelly 0 Comments

This is a case study of RiverVest's role in financing and guiding Cincinnati-based portfolio company Standard Bariatrics through acquisition by Teleflex, Inc....

Read More

13 Feb CASE STUDY: Lumena Pharmaceuticals

Posted at 16:07h in Case Study by Debbie Gerardi 0 Comments

RiverVest co-founded and seed funded Lumena and built a clinical strategy to fast-track its lead drug compound through clinical trials....

Read More

22 Jan CASE STUDY: Mirum Pharmaceuticals (Lumena 2.0)

Posted at 20:03h in Case Study by Rivervest 0 Comments

After the drug compound they developed was deprioritized, the Lumena team bought it back so they could finish what they started – getting kids with rare liver disease the relief they need. ...

Read More
logo-rivervest
St. Louis

101 S. Hanley Road, Suite 1850
St. Louis, MO 63105

Phone: (314) 726.6700

San Diego

10996 Torreyana Road, Suite 280
San Diego, CA 92121

Phone: (314) 726.6700

Cleveland

11000 Cedar Avenue
Cleveland, OH 44106

Phone: (216) 658.3982

RiverVest strives to improve the lives of patients, support entrepreneurs, and earn the trust of investors through science, strategy, and innovation.

Contact us at info@rivervest.com

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.OkLearn More